V. Aslan Et Al. , "Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma," Urologic Oncology: Seminars and Original Investigations , vol.40, no.11, 2022
Aslan, V. Et Al. 2022. Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations , vol.40, no.11 .
Aslan, V., Kılıç, A. C., Sütcüoğlu, O., Eraslan, E., Bayrak, A., Öksüzoğlu, B., ... Tahtacı, G.(2022). Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations , vol.40, no.11.
Aslan, VOLKAN Et Al. "Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma," Urologic Oncology: Seminars and Original Investigations , vol.40, no.11, 2022
Aslan, VOLKAN Et Al. "Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma." Urologic Oncology: Seminars and Original Investigations , vol.40, no.11, 2022
Aslan, V. Et Al. (2022) . "Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma." Urologic Oncology: Seminars and Original Investigations , vol.40, no.11.
@article{article, author={VOLKAN ASLAN Et Al. }, title={Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma}, journal={Urologic Oncology: Seminars and Original Investigations}, year=2022}